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Abstract 
 
Introduction: Greater accessibility to antibiotics has resulted in their excessive use, 
leading to increasing antimicrobial resistance (AMR) and strains on healthcare systems, 
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with only a limited number of patients in ambulatory care treated according to 
guidelines. High rates of AMR are now seen across countries and continents, resulting 
in AMR becoming one of the most critical issues facing healthcare systems. It is 
estimated that AMR could potentially cause over 10 million deaths per year by 2050 
unless addressed, resulting in appreciable economic consequences. There are also 
concerns with under-treatment especially if patients are forced to fund more expensive 
antibiotics as a result of AMR to first line antibiotics and do not have available funds. 
Over-prescribing of antibiotics is not helped by patient pressure even when physicians 
are aware of the issues. There is also extensive dispensing of antibiotics without a 
prescription; although this is now being addressed in some countries. Aim: Review 
interventions that have been instigated across continents and countries to reduce 
inappropriate antibiotic prescribing and dispensing, and associated AMR, to provide 
future guidance. Method: Narrative case history approach. Findings: A number of 
successful activities have been instigated to reduce inappropriate prescribing and 
dispensing of antibiotics across sectors. These include the instigation of quality 
indicators, suggested activities of pharmacists as well as single and multiple 
interventions among all key stakeholder groups. Conclusion: Multiple inter-linking 
strategies are typically needed to enhance appropriate antibiotic prescribing and 
dispensing. The impact of ongoing activities need to be continually analysed to provide 
future direction if AMR rates, and their impact on subsequent morbidity, mortality and 
costs, are to be reduced.  
 
1. Introduction 
 
1.1 Extent and threat of antimicrobial resistance and its impact on future 
healthcare and costs 
 
Before the discovery of antibiotics, infectious diseases were the principal cause of 
morbidity and mortality (Md Rezal et al., 2015). This changed with their advent (Bosch 
et al., 2008; Alharbi et al., 2014; HMG, 2014). Antibiotics have now become the 
cornerstone of treatment for bacterial infections across healthcare sectors(van de Sande-
Bruinsma et al., 2008; Holloway et al., 2011; WHO Europe, 2014; Laxminarayan et al., 
2015), and are seen as an essential part of modern medical practice(Hwang et al., 2015). 
As a result, they are now amongst the most prescribed and dispensed medicines across 
health care settings (Larsson et al., 2000; Jande et al., 2012; Kho et al, 2013; Almeman 
et al., 2014; Md Rezal et al., 2015; Podolsky et al, 2015; Truter, 2015). Antibiotic 
utilisation increased 36% globally between 2000 and 2010, with Brazil, China, India, 
South Africa and Russia accounting for 76% of this increase (Van Boeckel et al., 2014; 
Laxminarayan et al., 2015). This is set to continue unless addressed. 
 
Greater accessibility to antibiotics has resulted in their irrational and excessive use, 
leading to increasing antimicrobial resistance (AMR) and a concomitant strain on 
healthcare systems (Goossens et al., 2005; de Jong et al., 2008; van de Sande-Bruinsma 
et al., 2008; Davies et al., 2010; Kesselheim et al., 2010; de Kraker et al., 2013; Barnett 
et al., 2014; Versporten et al., 2014; Truter, 2015). For instance in Pakistan, the average 
number of antibiotics prescribed per physician encounter is 1.1 in ambulatory care and 
2.4 for inpatient care (Riaz et al., 2015). In Botswana, only 31% of children were 
correctly prescribed an antibiotic and 40.3% of children who did not require an 
antibiotic left the health facility with a prescription for one (IMCI, 2004). In Kenya, 
antibiotics were prescribed in two thirds of patients seeing a physician for diarrhoea 
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(Brooks et al., 2006). In Kampala, Uganda, there was also appreciable self-purchasing 
of antibiotics for acute respiratory tract infections (RTIs) including common colds, 
mainly amoxicillin and co-trimoxazole, before patients or their families sought medical 
help (Massele et al., 2015). Self-purchasing of antibiotics is also common in many other 
countries despite being illegal in most (Chatterjee and Fleck, 2011; Godman et al., 
2014; WHO Europe 2014; Massele et al., 2015; WHO, 2015), and is strongly correlated 
with increasing AMR rates in low-income and middle-income countries (LMICs) 
(Alsan et al., 2015).  
 
The consumption patterns of antibiotics among humans and its use in agriculture, 
especially in animal husbandry, have been found globally to correlate with the 
development of AMR (Oduyebo et al., 2008; Goossens, 2009; Meyer et al., 2013; 
Adesokan et al., 2015; Velickovic-Radovanovic et al., 2015). Resistant strains of 
bacteria have been isolated from food animals, plant source and dairy products in 
different parts of the world (Brookes et al., 2006; Goossens 2009; de Kraker et al., 
2013; WHO, 2015). The HIV/AIDS epidemic, especially on the African continent, 
coupled with the use of co-trimoxazole prophylaxis, has also increased AMR rates 
(Cotton et al., 2008; Marwa et al., 2015).  
 
In addition, only a limited number of ambulatory care patients with infections are 
currently treated according to guidelines. Over 40% of prescriptions for antibiotics are 
considered inappropriate particularly for upper respiratory tract infections (URTIs), 
which are typically viral in origin (Gonzales et al, 2001; Holloway et al., 2011; Little et 
al., 2013; Barnett et al., 2014; Hassali et al., 2015). For instance a study in the UK 
concluded that the complication rate after URTIs is very low and antibiotic therapy is 
ineffective. As a result, the authors estimated 4000 patients or more with URTIs need to 
be treated with antibiotics to prevent a single episode of pneumonia (Petersen et al., 
2007).  
 
2YHUDOO LW LV HVWLPDWHG WKDW UHVLVWDQFH UDWHV RI  DUH VHHQ ZRUOGZLGH WR FRPPRQ
bacteria such as Escherichia coli, Klebsiella pneumonia and Staphylococcus aureus 
(WHO, 2014). In 15 European countries, more than 10% of bloodstream 
Staphylococcus aureus infections are due to methicillin-resistant Staphylococcus aureus 
(MRSA), with seven of these countries having resistance rates above 25% (ECDPC, 
2015; HMG, 2014). High rates of antibiotic resistance are seen across Africa, the 
Middle East and Asia (Table 1), with 5 out of 6 WHO regions reporting high resistance 
rates leading to increased prescribing of second line antibiotics (WHO, 2014).  
 
For instance in Tanzania in children aged between 0±7 years with septicaemia, AMR 
was a major risk factor for a poor outcome (Blomberg et al., 2007). In Uganda in 
patients with surgical site infections, extended spectrum beta-lactamase (ESBL)-
producing Enterobacteriaceae and MRSA organisms were also major risk factors for a 
poor outcome (Seni et al., 2013). AMR is of particular concern in community settings 
where infections are common and can easily be transmitted among the population 
(NCCID, 2010; WHO, 2014). However, the true burden of bacterial infections in many 
African countries, including South Africa, remains unknown (Laxminarayan et al., 
2015; Mendelson et al., 2015).  
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Table 1 ± Antibiotic resistance rates among African, Middle East and Asia countries  
 
Country Antibiotic resistance patterns 
Asia x High prevalence of AMR across Asian countries (Jean et al., 2011; Kim 
et al, 2012; Kang et al., 2013; Lai et al., 2014) 
x The prevalence of Streptococcus pneumonia resistant to erythromycin is 
80.7% in Vietnam, 84.9% in Taiwan and 96.4% in China (Song et al., 
2004; Kim et al., 2012; Kang et al., 2013; Lai et al., 2014) 
Botswana x MRSA in 22.6% of isolates from skin and soft tissue infections from 
hospitalized children and adults (Wood et al., 2009) 
x Hospital antibiograms in 2013 and 2014 in a tertiary care hospital in 
northern Botswana showed Klebsiella pneumonia is resistant to most 
beta-lactam antibiotics with less than 50% sensitivities (Massele et al., 
2015) 
India and 
Pakistan  
x USWRRIDGXOWVKDYHEDFWHULDWKDWDUHUHVLVWDQWWRȕ-lactam 
antibiotics. This includes the carbapenems (Reardon, 2014) 
Kenya x Multi-drug resistant (MDR) NonǦtyphi Salmonella was 42% in 2003 
(Kariuki et al., 2005), and the estimated incidence of community-
acquired NonǦtyphi Salmonella was 166/ 100,000 people/ year for 
children <5 years (Berkley et al., 2005a). 35% of all NonǦtyphi 
Salmonella cases in newborns resulted in death in a National referral 
hospital (Kariuki et al., 2006) 
x MDR S. typhi was over 75% of all S. typhi among private clinics and the 
main referral hospital in Nairobi (Kariuki et al., 2010), with 43% of S. 
Pneumonia isolates in Nairobi resistant to penicillin (Kariuki et al., 
2003). The prevalence of MRSA was 33% of S. aureus isolates at a 
National referral hospital (Ngumi, 2006) 
x E. coli isolated from among hospital patients were highly resistant to 
commonly used antibiotics including ampicillin, amoxycillin/clavulanic 
acid, and trimethoprim/ sulphamethoxazole, with less resistance to 
ciprofloxacin and third-generation cephalosporins (Kiiru et al., 2012). In 
one region, resistance to E.coli was 85% tocotrimoxazole, 78% to 
amoxicillin and 42% to chloramphenicol (Bejon et al., 2005) 
x 50% of isolates of Haemophilus influenzae type B from children with 
severe pneumonia were resistant to penicillin (Berkley et al., 2005b) 
x 65% of the N. gonorrhoeae isolates were resistant to penicillin and 
plasmid-mediated tetracycline resistance was 97%. In 2007, quinolone-
resistant N. gonorrhoeae first appeared, increasing to 50% in 2009 
(Mehta et al., 2011) 
Malaysia x The National Surveillance on Antibiotic Resistance in 2014 reported an 
increase in antibiotic resistance rates among common strains of bacteria 
such as Streptococcus pneumonia, Enterobacter cloacae and Salmonella 
spp (Ahmad, 2014) 
x Hospital acquired pneumonia associated with Acinetobacter spp. 
showed a very high rate of resistance to imipenem (86.7%) (Kang et al., 
2013) 
x In a multicentre surveillance study, 60.6% of Streptococcus 
pneumococcus isolates were resistant to erythromycin (Kim et al., 2012) 
Nigeria x The susceptibility of antibiotics commonly used as empirical treatment 
for many infections in hospitals - especially those of the urinary tract, 
ear infections and post-operative wound infections - has declined 
considerably, e.g. as many as 88% of Staphylococcus aureus infections 
are resistant to methicillin (Reardon, 2014) 
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x Studies have reported susceptibility rates to empiric antibiotics below 
60% in urinary tract isolates and over 98% resistance to ȕ-lactam 
antibiotics in post-operative wound infections(Okesola et al., 2011; 
Muoneke et al., 2012; Dibua et al., 2014) 
x Studies have also reported susceptibility rates below 50% for antibiotics 
used for empirical treatment of patients with community acquired 
pneumonia (Iroezindu et al., 2014) 
South Africa 
(Mendelson et 
al., 2015) 
x 50% of all hospital-acquired S. aureus in public hospitals in 2010 were 
MRSA, with MRSA accounting for 75% of all hospital-acquired S. 
aureus infections in a large tertiary level paediatric hospital. 
x Enterococcus faecium bloodstream isolates from the private sector 
showed variable sensitivity to vancomycin, ranging between 33-100% 
depending on the geographical location 
x Up to 75% of K. pneumonia isolated from hospitalised patients were 
ESBL producing bacteria 
x 16% of carbapenem±susceptible Enterobacteriaceae in the private 
sector contained acarpapenemase producing gene, and Carpapenemase-
producing Enterobacteriaceae are widespread among public hospitals in 
South Africa 
Vietnam (Hoa et 
al., 2011; Van 
Nguyen et al., 
2013; Van et al., 
2014) 
x Pneumococcal penicillin-resistance rates are typically the highest in 
Asia, with carbapenem-resistant bacteria (notably NDM-1) recently 
emerging 
x Streptococcus pneumoniae penicillin-resistance rates increased from 8% 
to 75% from 1999 to 2007 in Ba Vi, not helped by high rates of self-
purchasing of antibiotics (Table 3) 
x More than 90% of isolates from principally patients in an intensive care 
unit in Hanoi tested for resistance to A. baumannii were resistant to 
tested b-lactamase inhibitors/ b-lactamase, carbapenems,cephalosporins, 
fluoroquinolones and trimethoprim/sulfamethoxazole. Overall, 25.4% of 
isolates were resistant to all tested aminoglycosides, b-lactams and 
quinolones 
x There has been a significant increase in resistance of Streptococcus suis 
to tetracycline and chloramphenicol in isolates between 1997and 2008, 
concurrent with an increase in multi-drug resistance organisms 
 
MRSA is also a common problem worldwide. New community-acquired strains of 
MRSA (CA-MRSA) are also now emerging causing concern (FIP, 2008).  
 
Increasing AMR rates is now seen as one of the most critical problems facing healthcare 
systems (WHO, 2001; Sumpradit et al., 2012; Barlam et al., 2015; Hoffman et al., 
2015a). It is estimated that AMR infections currently cause approximately 50,000 
deaths a year in Europe and the US alone (HMG,2014). This increases to several 
hundred thousand deaths each year when other countries are included (HMG,2014). The 
continual rise in AMR could result in it becoming a leading cause of death worldwide 
by 2050 with over 10 million deaths per year, potentially reducing GDP by 2% to 3.5% 
and costing up to US$100 trillion (HMG, 2014; Md Rezal et al., 2015). Other authors 
have suggested lower costs; however, their estimates typically fail to consider the costs 
for patients or health authorities after patients are discharged from hospitals (Gandra et 
al., 2014). 
 
As a result of increasing AMR rates, common infections are becoming more difficult to 
treat, causing life-threatening illnesses and potentially death (Costelloe et al., 2010). 
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This combination of overuse of antibiotics, misuse, stopping treatment before courses 
are finished, cultural differences, and under use due to a lack of access and financial 
support, are seen as key drivers of AMR (WHO Europe, 2014; Klein et al., 2015; 
Laxminarayan et al., 2015; Md Rezal et al., 2015). These factors lead to the 
phenomenon which has been termed selective pressure (WHO, 2001).As mentioned, 
increasing antibiotic resistance poses a threat to health and healthcare systems across 
countries as it can lead to high associated costs (Van Nguyen et al., 2013), for example 
forcing a shift to more expensive and more broad spectrum antibiotics (Laxminarayan et 
al., 2012; Md Rezal et al., 2015).  
 
Improving the rational use of antibiotics is one of the best ways to slow down the 
development and spread of AMR (van de Sande-Bruinsma et al, 2008; Sumpradit et al., 
2012; Earnshaw et al., 2013). This means addressing issues such DVSK\VLFLDQV¶ODFNRI
adherence to treatment guidelines and their lack of knowledge and training regarding 
antibiotics, the lack of diagnostic facilities as well as uncertainty over the diagnosis, 
pressures from patients and the pharmaceutical industry, and finally fear of clinical 
failure (Little et al., 2013; Van Nguyen et al., 2013; Hassali et al., 2015; Md Rezal et al., 
2015; Riaz et al., 2015). In LMIC countries and others, this also includes implementing 
regulations surrounding the dispensing of antibiotics including self-purchasing where 
this is a concern (Radyowijati et al., 2003; Kotwani et al., 2010; Li et al., 2012; Van 
Nguyen et al., 2013; Holloway et al., 2014; Holloway et al., 2015).  
 
Adoption of antimicrobial resistance strategies in countries including South Africa and 
Vietnam as well as the WHO Europe strategic action plan on AMR, the recent WHO 
global report on antimicrobial resistance documenting alarming levels of AMR in many 
countries and the endorsement of the Global Action Plan for Antimicrobial Resistance 
in May 2015 are seen as important steps to help reduce AMR (WHO Europe, 2011; 
Department of Health RSA, 2014; WHO, 2014; Abdula et al., 2015; Cluzeau et al., 
2015; Mendelson et al., 2015). 
 
1.2 Physician attitudes towards antibiotics 
 
A recent systematic review showed that physicians still have limited knowledge and 
misconceptions about antibiotics and their prescribing (Md Rezal et al., 2015). In 
addition, some physicians still prescribed antibiotics despite knowing they are generally 
of limited benefit in a number of situations (Md Rezal et al., 2015). For instance in 
Brazil, 38.2% of interviewed patients declared that they had taken antibiotics in the 
previous 6 months. For patients who had received an antibiotic prescription for 
oral/dental infections, only 9.3% presented with a fever, indicating over prescribing of 
antibiotics by physicians (Del Fiol et al., 2010).  
 
Several factors influence physician prescribing of antibiotics. These include the severity 
and duration of infections, expectations of patients, uncertainty over diagnosis, the risk 
of losing patients, and pharmaceutical company influence (Md Rezal et al., 2015). 
Inadequate knowledge regarding the prescribing of antibiotics appears prevalent among 
physicians across countries. However, many physicians are interested in addressing this 
to help reduce AMR rates (Md Rezal et al., 2015). Qualitative research undertaken by 
Thatoyaone Kenaope and colleagues also found that among pharmacists in South 
Africa, the socio-economic status of patients, patient satisfaction, their knowledge of 
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antibiotic indications and the professional relationships between healthcare 
professionals also influenced physician prescribing behaviour (Massele et al., 2015). 
 
To be able to successfully reduce AMR rates, physicians need to be knowledgeable 
about the prevailing epidemiology of infections and current antimicrobial sensitivity 
status in their location as well as strictly comply with evidence based treatment 
guidelines. However, across-national study conducted among physicians in England and 
France found only 31% and 26% of physicians respectively knew the correct prevalence 
of antibiotic misuse and of MRSA in their hospitals (Pulcini et al., 2011). Among 
medical doctors and students in the Congo Democratic Republic, there was very limited 
knowledge of local antimicrobial resistance patterns (Thriemer et al., 2013). These and 
other studies demonstrate the need to tackle all key stakeholder groups to enhance 
appropriate prescribing and dispensing of antibiotics. 
 
1.3 Antibiotic prescribing and dispensing in pharmacies  
 
There is a large body of literature discussing SKDUPDFLVWV¶ DQWLELRWic dispensing 
practices across countries, e.g. in Kenya 25% of the population go to retail pharmacies 
first before seeking out-patient care (Sharma et al, 2008; Thoithi et al, 2009). This is 
illustrated by 24% of patients with symptoms of acute RTIs in rural Kenya already 
purchasing an antibiotic from pharmacies before seeing a physician (Bigogo et al., 
2010).  
 
As mentioned, dispensing of antibiotics without a prescription, albeit unlawful, is 
common. Countries where this happens include Albania (Hoxha et al., 2015), Brazil 
(Rauber et al., 2009), Egypt (Dooling et al., 2014; Sabry et al, 2014), Greece 
(Contopoulos-Ioannidis et al., 2001; Plachouras et al, 2010), India (Kotwani et al., 
2012; Salunkhe et al., 2013), Iraq (Mikhael, 2014), Jordan (Almaaytah et al., 2015), 
Lebanon (Farah et al, 2015), Portugal (Roque et al., 2014; Roque et al., 2013), Saudi 
Arabia (Abdulhak et al., 2011; Emeka et al., 2012; Al-Mohamadi et al., 2013), Serbia 
(Godman et al., 2014), Spain (Zapata-Cachafeiro et al., 2014), Syria (Bahnassi, 2015) 
and the United Arab Emirates (Abasaeed et al., 2013). Table 2 illustrates the extent of 
self-purchasing across countries. 
 
Table 2. Examples of the extent of dispensing antibiotics without a prescription 
 
Authors Country Extent of dispensing antibiotics 
without a prescription (%) 
Hoxha et al.,2015 Albania 80.0 
Farah et al., 2015 Beirut, Lebanon 32.0 
Volpato et al, 2005* Brazil 74.0 
Almaaytah et a.l, 2015 Jordan 74.3 
Salunkhe et al., 2013 Pune, India 94.7 
Abdulhak et al., 2011 Riyadh, Saudi Arabia 77.6 
*NB Studies conducted before prescription requirements in November 2010 among private pharmacies. 
 
However in some countries such as Thailand, pharmacists are allowed to dispense 
antibiotics without a prescription (Saengcharoen et al., 2008). Among the wider 
European countries including former Soviet Union countries, it is also currently 
possible and legal to purchase antibiotics over-the-counter (OTC) without a prescription 
in 19 out of the 44 countries (WHO Europe, 2014), and this is also possible outside of 
pharmacies (12 out of 44 countries). In 5 out of the 44 countries surveyed, it is also 
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possible to purchase antibiotics over the internet without a prescription (WHO Europe, 
2014). The situation is different in many high-income countries where regulations are 
typically strictly implemented, e.g. New Zealand (Dameh et al., 2012).  
 
Among many Latin American countries, including Brazil and Mexico, restrictions on 
OTC sales of antibiotics were implemented in 2010 (Santa-Ana-Tellez et al., 2015). 
This included the requirement for a prescription for antibiotics to be dispensed even in 
private pharmacies. A prescription for antibiotics was always a requirement among 
public pharmacies in Brazil. A recent study showed a reduction in inappropriate 
penicillin use (as proxy for antibiotics use) among private pharmacies in Mexico after 
this government initiative (Santa-Ana-Tellez et al., 2015); although, a limited reduction 
in Brazil. However, another study showed a significant decrease in antimicrobial sales 
among private pharmacies in Brazil following the restrictions in November 2010 
(Moura et al., 2015). The impact of the restrictions was greater in regions with overall 
higher socio-economic status (Moura et al., 2015). 
 
In a systematic review of published work on antibiotic self-medication in developing 
countries, the overall prevalence of antimicrobial self-medication was 38.8%. Identified 
determinants of self-PHGLFDWLRQ ZHUH FLWL]HQV¶ DJH OHYHO RI HGXFDWLRQ VH[ LQFRPH
severity of their disease condition and history of previous successful use of antibiotics 
(Ocan et al., 2015). Table 3 contains additional data on the extent of self purchasing. 
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Table 3 ± Extent of self purchasing of antibiotics across continents and countries 
(building on Table 2) 
 
Countries Extent of self purchasing 
Brazil* x In a study conducted in Tubarão, 85.0% of pharmacists dispensed an 
antibiotic without a prescription, mainly for the treatment of respiratory 
(62.8%) and urinary (12.0%) tract disorders. In most cases, this was for 
adults (64.0%), but also children (27.8%), the elderly (3.3%) and for 
pregnant women (1.6%) (Rauber et al., 2009) 
x In Jataí, antibiotic self-medication was seen in 9.1% of participants; 
however, 9.1% used antibiotics as recommended by pharmacists in the 
last month. 20.5% of responders also traditionally recommend the use 
of antimicrobials to family and friends (Braoios et al., 2013) 
x In a population-based study inBambuí, self-medication in the last 90 
days was reported for 28% of the 1,221 resident and antibiotics and 
chemotherapeutics accounted for 6.2% of non-prescribed drugs (Loyola 
Filho et al., 2002) 
Ethiopia 
(Gebeyehu et al., 
2015) 
x Antibiotic self-medication was common among community dwellers 
with RTIs, diarrhoea and physical injury 
Greece (Mitsi et 
al., 2005) 
x 74.6% of the general public reported taking non-prescribed antibiotics  
Northern Israel 
(Raz et al., 2005) 
x 18.7% of the general public reported taking antibiotics without seeking 
medical advice  
Kenya 
(Karambu, 2011) 
x 70% of sampled pharmacies did not ask patients for a prescription 
before dispensing antibiotics as required by the law 
x In addition, only 9% of pharmacies asked for a prescription and 18% 
declined to sell the antibiotics after a prescription was presented  
Malaysia 
(Islahudin et al., 
2014) 
x 45.1% of patients did not consult a physician before taking antibiotics  
Middle East/ 
Jordan 
x Specifically in Jordan among Middle-East countries, self-medication 
with antibiotics is high (39.5%). This is significantly associated with 
age, education and income(Al-Azzam et al., 2007) 
x A high level of self-medication (40.7%) was also reported in another 
Jordanian study (Sawair et al., 2009). 
Nigeria (Enato et 
al., 2011). 
x In a community based study conducted in the southern part of Nigeria, 
over 93.6% of community dwellers who reported they were ill self-
medicated with antibiotics  
Serbia x Illegal self-purchasing of antibiotics increased their utilisation by 115% 
to 128% in recent years compared with reimbursed utilisation (Godman 
et al., 2014) 
x This resulted in Serbia having the 3rdhighest utilization for 
cephalosporins in 2007 among European countries, highest for 
penicillins, 2ndhighest for macrolides and 3rdhighest for quinolones 
(Bajcetic et al., 2012) 
x Following this, there has been tightening of the regulations regarding 
self -purchasing in pharmacies, leading to a decrease in overall 
utilization in recent years (Godman et al., 2014) 
Vietnam (Van 
Nguyen et al., 
2013; Cluzeau 
et al., 2015) 
x The Pharmaceutical Law (2005) made antibiotics prescription-only 
medicines; however, there are currently no sanctions. In addition, no 
pharmacist has been penalized for dispensing antibiotics without a 
prescription (as of March 2013) 
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x Self-medication persists as it avoids lengthy and costly consultations 
with physicians and others in the formal healthcare systems  
x 91% of children in Ba Viin Vietnam in 1991 with symptoms of acute 
RTIs were treated with broad-spectrum penicillins, with 78% self-
medicating. This corresponded to 75% of all children in this particular 
community 
x This is likely to change with the implementation of the National Plan to 
reduce antimicrobial resistance rates in Vietnam 
* NB: All studies conducted before the changes in the law in Brazil 
 
Several studies have reported that pharmacists have dispensed antibiotics for 
inappropriate conditions (Kotwani et al., 2012; Salunkhe et al., 2013; Dooling et al., 
2014; Mikhael, 2014; Sabry et al., 2014), e.g. in Iraq, 45% of community pharmacists 
dispensed antibiotics for a common cold. Community pharmacists also dispensed 
several types of antibiotics including amoxicillin, amoxicillin/clavulanate, azithromycin 
and ciprofloxacin (Mikhael, 2014). In India, azithromycin was commonly dispensed for 
a sore throat in 51.2% of cases. Furthermore, antibiotics for a sore throat were only 
dispensed in correct doses and durations in 64.2% of cases (Salunkhe et al., 2013). 
 
Consequently, pharmacists in many countries play a key role with enhancing the 
appropriate use of antibiotics given the extent of self-purchasing (WHO Europe, 2014) 
(Tables 2 and 3). This, coupled with concerns with appropriate prescribing and rising 
AMR rates, led FIP (International Pharmaceutical Federation) to urge pharmacists to 
undertake a number of activities to reduce this, supported by suggested activities among 
health authorities and governments (Box 1). 
 
Box 1 ± Suggested activities of pharmacists to reduce AMR [Adapted from (FIP, 2008)] 
 
A) FIP urges pharmacists to:  
x Patients given proper counselling as well as provided with written information that is appropriate 
when dispensing antibiotics. In addition, encourage patients to comply with the full prescribed 
regimen. If not possible, ask them to dispose of any unused antibiotics appropriately 
x Work with physicians to ensure patients complete their course and correct antibiotics and doses are 
prescribed by providing up-to-date information. Similarly for other healthcare professionals 
influencing or administering antibiotics 
x Monitor the supply of antibiotics 
x Recommend treatments other than antibiotics for minor conditions such as a common cold 
x Become actively involved regarding hygiene and infection control across health care settings  
 
B) FIP urges governments and health authorities to:  
x Implement antimicrobial surveillance plans nationally including monitoring of antibiotic utilisation in 
agriculture, humans, and veterinary medicine 
x Implement measures to enhance the appropriate use of antibiotics as well as stop their sale/ 
dispensing without a prescription or order from a qualified healthcare professional. This includes 
measures to strengthen regulatory and legislative controls regarding the supply antibiotics including 
the enforcement of any statutes and regulations to improve the rational use and dispensing of 
antibiotics 
x Impose restrictions on the prescribing of selected antibiotics; the objective being to limit 
development of AMR 
x Conduct education campaigns among all key groups to help promote the appropriate use of 
antibiotics. In addition, collaborate with all health professional societies to develop and help 
implement educational and behavioural interventions to improve appropriate antibiotic prescribing 
x Help with establishing infection control programs to reduce AMR  
x Instigate methods to dispose of antibiotics where necessary that are environmentally sound 
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The WHO in Europe has also produced guidance encouraging the prudent use of 
antibiotics including the role of pharmacists (WHO Europe, 2014). This is alongside 
documenting 7 key areas on potential ways to reduce AMR rates across Europe (Box 2).  
 
Box 2 ± 7 key action areas identified by WHO Europe to address AMR [Adapted from 
(WHO Europe, 2014)] 
 
x To strengthen co-ordination across healthcare sectors and personnel 
x To strengthen the surveillance of AMR rates as well as antibiotic utilisation patterns among the 
countries in WHO Europe 
x Instigate measures to enhance the rational use of antibiotics (building on existing programmes) 
x Strengthen infection control across all health-care settings 
x Instigate measures to help prevent emerging antibiotic resistance strains in food and veterinary 
sectors 
x Help instigate appropriate measures that help promote research into new antibiotics given their 
current scarcity 
x Improve awareness including partnerships to promote patient safety and reduce AMR rates across 
Europe 
 
Other authors and organisations have also endorsed the need for greater education of 
pharmacists regarding antibiotics during their training (Ahmad et al., 2015).  
 
1.4 Public knowledge and attitudes towards antibiotics 
 
Published studies have shown that there is a general lack of knowledge about antibiotics 
among the general public (Eng et al., 2003; McNulty et al., 2007a; Grigoryan et al., 
2008; You et al., 2008; André et al., 2010; Oh et al., 2011; Al-Haddad., 2012; Chan et 
al., 2012; Lim &The., 2012; Napolitano et al., 2013; Van Nguyen et al., 2013; Fatokun, 
2014; Islahudin et al., 2014; Gualano et al., 2015; WHO, 2015). Even in some countries 
in which public awareness campaigns on antibiotics had been conducted, there was still 
widespread belief that antibiotics are effective against viral infections (WHO, 2014). 
Further inappropriate antibiotic prescribing, including unnecessary prescribing of 
antibiotics, has heightened public perceptions that these medicines are first-line 
treatment for common infections such as URTIs. These perceptions do lead patients to 
pressurize physicians to prescribe antibiotics regardless of the indication (Hassali et al., 
2015; Md Rezal et al., 2015)7KHVHSUHVVXUHVDUHHQKDQFHGE\SDWLHQWV¶ perception of 
antibiotics as powerful therapies, with the ability to quickly stop symptoms (Sharma et 
al., 2008). 
 
Gualano et al (Gualano et al., 2015) recently conducted a systematic review regarding 
public knowledge and attitudes towards antibiotics. The authors demonstrated that 
53.9% of the general public believed antibiotics can be used to treat viral infections, 
with 50.9% perceiving antibiotics can be used to reduce inflammation with 33.7% 
unaware that antibiotics should only be used to treat bacterial infections. 
 
There are also concerns that the public do not take their antibiotics according to the 
instructions on the label, take incomplete courses, take leftover antibiotics from 
previous treatments and share their antibiotics with others, particularly in LMICs (Zarb 
et al., 2012). For instance in Bangladesh, 51.4% of the general public did not take their 
antibiotics according to the label instructions (Sutradhar et al., 2014), and in Brazil, 
30% of those interviewed could have had their antibiotic treatment compromised by 
ignoring their current diagnosis (the indication for which an antibiotic was prescribed); 
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for not understanding the dosage and administration schedule; or both (Nicolini et al., 
2008). 
 
In Asia, Europe, North America and Oceania, 47.1% of patients stopped taking 
antibiotics when their symptoms disappeared (Gualano et al. , 2015). In Tetovo in the 
Republic of Macedonia, 60.8% of parents kept leftover antibiotics at home for future 
use (Alili-Idrizi et al., 2014), whilst 25% of the general population in Belgium, 
Colombia, France, Italy, Morocco, Spain, Thailand, Turkey and the United Kingdom 
also saved leftover antibiotics for future use (Pechere, 2001). In Taiwan, 13% of the 
general public shared their antibiotics with their family and friends (Chen et al, 2005). 
This compares to 8% in similar studies in Hong Kong and Malaysia (You et al., 2008; 
Al-Haddad, 2012). 
 
Several studies have shown a strong association between patient expectations and 
demands with excessive prescribing of antibiotics (Hamm et al, 1996; Macfarlane et al, 
1997; Mangione-Smith et al, 1999; Gonzales, 2005; Mustafa et al, 2014). In Malaysia, 
73.8% of the general population expect physicians to prescribe antibiotics for a common 
cold (Lim & Teh, 2012); whilst in Oklahoma, USA, approximately 65% of patients with 
respiratory infections expected to be prescribed antibiotics (Hamm et al., 1996). This 
may be because public awareness of antibiotic resistance is low across countries 
(Hawkings et al., 2007; Brooks et al., 2008; Brookes-Howell et al., 2012; Wun et al., 
2013; Gualano et al., 2015; WHO, 2015).  
 
Several studies have also explored public knowledge and perceptions of antibiotic 
resistance in Europe (Brookes-Howell et al., 2012), South India (Chandy et al., 2013) 
and the United Kingdom (Hawkings et al, 2007; Brooks et al, 2008). Most of the public 
had heard of antibiotic resistance but only a minority had the correct understanding of 
this term. The public RIWHQ XQGHUVWRRG WKH WHUP µDQWLELRWLF UHVLVWDQFH¶ DV WKH ERG\
getting used to or becoming immune to antibiotics. Other members perceived antibiotic 
resistance as the body becoming incompatible with antibiotics, the illness becoming too 
strong for antibiotics to manage, and it is a hereditary illness (Brookes-Howell et al., 
2012).  
 
Most of the general public are also unaware of the causes and consequences of 
antibiotic resistance. In addition, they attributed antibiotic resistance to external factors 
such as overprescribing of antibiotics by physicians as opposed to internal factors, e.g. 
non-adherence to antibiotic therapy. As a result, they typically do not perceive 
themselves as being responsible for preventing the misuse of antibiotics (Hawkings et 
al., 2007; Brooks et al., 2008).  
 
1.5 The need for public engagement to combat antibiotic resistance 
 
In view of these misconceptions, public campaigns and engagement are needed to 
increase SDWLHQWV¶ knowledge about antibiotics and antibiotic resistance. Public 
HQJDJHPHQW KDV EHHQ EURDGO\ GHILQHG DV ³LQYROYLQJ WKH JHQHUDO SXEOLF LQ GHFLVLRQ-
making and in the planning, design, governanFH DQGGHOLYHU\RI LQLWLDWLYHV´ (2¶0DUD-
Eves et al., 2013). 
 
In this context, the School of Pharmaceutical Sciences of Universiti Sains Malaysia, in 
collaboration with Action on Antibiotic Resistance (ReAct), has taken the initiative to 
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engage Yayasan Bina Ilmu (YBI) in addressing antibiotic resistance at the community 
level in Jelutong District, Penang, Malaysia. The School offers support and materials to 
the organization to undertake relevant work on antibiotic resistance, in line with their 
focus areas. Coordination, communication and commitment among all stakeholders play 
a key role in making this approach a success, with the findings used to support the 
development and implementation of a national policy to manage antibiotic resistance at 
the community level in Malaysia (Irawati et al., 2015). 
 
2. Aims 
 
Given the global importance of AMR, there is a need to review potential interventions 
and measures that have been instigated across continents, countries and regions to 
improve antibiotic utilization. Consequently, the aim of this chapter is to review 
interventions that have been introduced to reduce inappropriate prescribing and 
dispensing of antibiotics, and associated reduction in AMR, and their effectiveness to 
provide future guidance. This is seen as a conservatism strategy (Hoffman et al., 2015a).  
 
It is recognized that alongside this, strategies must be instigated to enhance the 
development of new antibiotics to address current unmet need as well as limit their 
utilization to very targeted populations once launched (Hoffman et al., 2015a; Hoffman 
et al., 2015b; Outterson et al., 2015). This will potentially involve new methods of 
funding research (Brogan et al., 2013; Balasegaram et al., 2015; Hwang et al., 2015; 
Outterson et al., 2015). There is also a need for restrictions on the use of antibiotics in 
animals with for instance the utilization of antibiotics in animals in the US at least three 
times greater than the overall use in humans (So et al., 2015). However, new funding 
models for financing antibiotic research as well as programmes to reduce antibiotic use 
in animals are outside the scope of this chapter. 
 
3. Methods  
 
A narrative review of publications, including case histories, known to the co-authors to 
provide future guidance. This is because systematic reviews of potential approaches to 
improve the utilisation of antibiotics have already been undertaken by the co-authors 
and others (Huttner et al., 2010; Dar et al., 2015; Md Rezal et al., 2015).  
 
We have undertaken similar approaches when reviewing measures to enhance the 
prescribing and dispensing of generics as well as initiatives to optimise the use of new 
medicines (Godman et al., 2012; Dylst et al., 2013; Godman et al., 2013; Godman et al., 
2014; Godman et al., 2015). 
 
4. Findings 
 
The case histories will be divided into hospitals and ambulatory care. This will include 
the findings of meta-analyses as well as country and regional studies. There will also be 
a review of the impact of educational interventions on public knowledge and attitudes 
towards antibiotics and resistance. 
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4.1 Hospitals 
 
x Meta-analysis (Cochrane review) (Davey et al., 2013) 
 
This meta-analysis included 95 interventions principally targeting antibiotic prescribing. 
This included antibiotic choices as well as the timing of first dose and the route of 
administration. There was reliable data from 76 interventions including persuasive 
(majority), restrictive and structural interventions. Interventions that were restrictive in 
nature had a significantly greater impact on subsequent outcomes at one month and 6 
months. However, there were no significant differences between the different 
interventions on outcomes at 12 or 24 months.  
 
There was a reduction in Clostridium difficile infections as well as a reduction in the 
colonization or infections with resistant bacteria, including cephalosporin-resistant and 
aminoglycoside-resistant gram-negative bacteria, vancomycin-resistant Enterococcus 
faecalis and MRSA, with interventions that sought to reduce excessive antibiotic 
prescribing. There was also a significant reduction in mortality in interventions 
instigated to improve antibiotic prescribing in patients with pneumonia. 
 
x China (Zou et al., 2014) 
 
There have been considerable concerns regarding the over-use of antibiotics in China, 
driven by incentive systems for hospitals and physicians encouraging the use of IV 
versus oral antibiotics as well as their overuse (Reynolds et al., 2009; 2011). However, 
antibiotic prescribing is changing following a nationwide campaign instigating 
antibiotic stewardship programmes (ASPs) to address their over-use and AMR rates. A 
recent study assessing the impact of this nationwide campaign showed the following 
between 2011 and 2012: 
x Decreasing antibiotic use (26.54 instead of 39.37 DDDs/100 inpatient days) 
x Decreasing % of antibiotics among outpatient prescriptions and their use in hospital 
inpatients over the two years 
x Correlation between subsequent antibiotic utilisation and the type and size of 
specialized hospitals; however not with the region 
 
x Scotland 
 
SAPG (Scottish Antimicrobial Prescribing Group) was established in Scotland in 2008 
to coordinate a national antimicrobial stewardship programme (Nathwani et al., 2011). 
The collection of prevalence data in 2009 led to the development of two quality 
prescribing indicators: (i) the extent of compliance with antibiotic policies among acute 
admission units and (ii) surgical prophylaxis duration (Malcolm et al., 2013). Studies 
showed compliance with current antibiotic policies (81.0%) were similar to other 
European countries; however, the duration of surgical prophylaxis <24hr (68.6%) was 
higher than generally seen across Europe.  
 
Following the implementation of prescribing indicators, there was an improvement in 
the indication noted in the patient records RI  &ompliance with antibiotic 
prescribing policies also increased to 90% (Malcolm et al., 2013), with the mean 
proportion of patients receiving single dose prophylaxis following colorectal surgery 
exceeding95% (the target). Overall, SAPG has shown that the implementation of 
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national prescribing indicators, which are acceptable to clinicians and regularly audited, 
can improve subsequent antibiotic utilisation (Malcolm et al., 2013).  
 
x Zambia (Mubita et al, 2013; Massele et al., 2015) 
 
Mubita et al conducted a prospective quasi-experimental clinical audit project among 
Internal Medicine wards at a University Teaching Hospital in Zambia. The findings 
showed that the implementation of an antimicrobial prescribing care bundle was 
associated with an improvement in the quality of antibiotic prescribing in terms of 
compliance with its care elements.  
 
A pilot study was undertaken to assess the implementation of an adapted antimicrobial 
prescribing care bundle. Subsequently, compare compliance of antimicrobial 
prescribing with the care elements (standards) of the antimicrobial prescribing care 
bundle before and after implementation. Implementation of the bundle involved 
educational programmes on antimicrobial stewardship. Topics covered included the 
antimicrobial prescribing care bundle, standard treatment guidelines on infections and 
the hospital antibiogram. Feedback on the control phase results was communicated to 
the prescribers. Posters of the Antimicrobial Stewardship-treatment algorithm were 
displayed within the medical wards. Pocket-VL]HGFDUGVRIWKH3UHVFULEHUV¶&KHFNOLVWDV
an aide ± memoire were distributed to all prescribers in Internal Medicine. 
 
2XWFRPH PHDVXUHV ZHUH FRPSOLDQFH ZLWK WKH FDUH EXQGOH¶V FDUH HOements as audit 
standards as well as: 
x Presence of clinical evidence of bacterial infection 
x Documentation of the clinical indication for antibiotics, the duration or review date 
as well as the route and dose of antibiotics prescribed 
x Collection of appropriate culture specimens 
x Appropriate empirical selection of antibiotics 
x Documentation of appropriate prescribing decision option by 48 hours of 
antimicrobial therapy. 
 
Table 4 shows a summary of the findings of the clinical audit project. 
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Table 4: Findings of the clinical audit project conducted in a teaching hospital in 
Zambia 
 
Care element (audit standard) 
Compliance level n (%) 
 ࢖  
Control 
Phase 
( n = 128) 
 
Intervention 
Phase 
(n = 128) 
Clinical evidence of bacterial infection 112(87.5) 116(90.6) 0.022 
Documentation of the clinical indication, the 
duration or review date as well as the route and 
dose of antibiotics 
9(7) 58(45.3) 0.522 
Culture specimens collected according to standard 
treatment guidelines 
84(65.6) 92(71.9) <0.001 
Appropriate empirical selection of antibiotics, i.e. 
prescribing according to standard treatment 
guidelines at initiation of antibiotics 
73(57) 80(62.5) 0.333 
Documentation of appropriate prescribing 
decision option by 48 hours of antimicrobial 
therapy. 
64(50) 83(64.8) <0.001 
Overall compliance 7(5.5) 46(35.9) 0.044 
 
This study recommended implementation of a formal antimicrobial stewardship 
programme among Internal Medicine Wards in Zambia. This would involve 
establishing multidisciplinary antimicrobial stewardship teams in hospitals with core 
membership comprising the following: an infectious diseases physician, a clinical 
microbiologist and a clinical pharmacist with expertise in infectious diseases. 
 
4.2 Ambulatory care (settings, regions and countries) 
 
4.2.1 Pharmacy dispensing 
 
Chapter 1.3 together with Boxes 1 and 2 describe potential ways forward for 
pharmacists and others to reduce inappropriate dispensing and use of antibiotics. We are 
already seeing a number of countries tighten illegal self-purchasing of antibiotics, e.g. 
Brazil (private sector), Mexico and Serbia, and this will grow (Godman et al., 2014; 
Moura et al., 2015, Santa-Ana-Tellez et al., 2015). 
 
4.2.2 European Surveillance of Antimicrobial Consumption (ESAC) 
 
ESAC have suggested a number of aggregated and patient level quality indicators to 
improve future use of antibiotics. These include: 
 
Aggregated indexes (in defined daily doses/ 1000 inhabitants/ day ± DIDs) (Coenen et 
al., 2007): 
x % combination pencillins including ß-lactamase-sensitive penicillins vs. All 
antibiotics  
x % of 3rd and 4th generation cephalosporins vs. 1st and 2nd generation cephalosporins 
(and all antibiotics) 
x % fluroquinolones vs. All antibiotics 
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x % Broad vs. Narrow penicillins, cephalosporins and macrolides 
 
Quality indicators where patient level data is available include (Adriaenssens et al., 
2011):  
x % of patients between 18 and 75 years with acute bronchitis prescribed antibiotics 
(acceptable range 0 ± 30%); within this % those receiving recommended antibiotics 
(acceptable range 80 ± 100%) or fluoroquinolones (acceptable range 0 ± 5%) 
x % of patients older than one year with upper respiratory tract infections (URTIs) 
prescribed antibiotics for systemic use (acceptable range 0 ± 20%); within this % 
receiving recommended antibiotics (acceptable range 80 ± 100%) or 
fluoroquinolones (acceptable range 0 ± 5%) 
 
4.2.3 Internet-based training on antibiotic prescribing rates for patients with acute 
RTIs (Little et al., 2013) 
 
Primary-care practices among six European countries were randomised to (i) usual care, 
(ii) training in the use of a C-reactive protein (CRP) tests at the point of care, (iii) 
training in enhanced communication skills, or (iv) in both training in CRP and enhanced 
communication via the internet. 
 
The study showed that antibiotic prescribing rates were lower with training in CRP tests 
and lower in practices with enhanced-communication training than without such. The 
greatest reduction in subsequent antibiotic prescribing was seen when the interventions 
were combined. 
 
The authors concluded that Internet training did achieve important reductions in 
antibiotic prescribing for RTIs across languages and cultures. Consequently, a potential 
way forward to enhance appropriate antibiotic prescribing across countries where 
resources are limited. 
 
4.2.4 Belgium (WHO Europe, 2011) 
 
Since 2000, national campaigns among GPs and communities on the prudent use of 
antibiotics have been organized by the Belgian Antibiotic Policy Coordination 
Committee. Alongside this, establishing surveillance systems across healthcare sectors, 
improving legislation on hospital hygiene, and disseminating guidelines on the 
prevention and treatment of bacterial infections. 
 
These multifaceted campaigns resulted in a steady decrease (6.2%/ year) in the use of 
antibiotics in ambulatory care in recent years. In addition, the correct use of antibiotics 
is also increasing across sectors and resistance to streptococcal infections steadily 
declining. 
 
Similar successful campaigns have been initiated in other countries including France, 
Spain, Poland and the UK. 
 
4.2.5 France (Sabuncu et al., 2009) 
 
Among European countries, France typically has the highest rate of antibiotic 
consumption and beta-lactam resistance in Streptococcus spp. This resulted in the 
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French government instigating in 2001 a programme entitled µµ.HHS $QWLELRWLFV
WorkinJ¶¶ WKH main component being µµ/HV DQWLELRWLTXHVF¶HVW SDV DXWRPDWLTXH¶¶
µµ$QWLELRWLFVDUHQRWDXWRPDWLF¶¶ 
 
Compared to the pre-intervention period (2000±2002): 
x Decrease by 226.5% over 5 years in the number of antibiotic prescriptions, 
adjusted for flu-like syndrome frequency during the winter season 
x This decline in antibiotic utilisation occurred throughout France, which affected all 
antibiotic classes except quinolones 
x The greatest decrease in antibiotic utilisation was seen among young children (6 to 
15 years of age) 
 
The authors concluded that this multifaceted campaign was associated with an 
appreciable reduction in unnecessary antibiotic prescribing. This was particularly in 
children.  
 
4.2.6 Italy (Formoso et al, 2013) 
 
Interventions to try and reduce antibiotic prescribing among the public included posters, 
brochures and adverts in the local media. There was also a newsletter on local antibiotic 
resistance targeting physicians and pharmacists. The design of the materials and 
messages was facilitated by GPs and paediatricians working in the intervention locality. 
 
Antibiotic prescribing was significantly reduced in the intervention locality compared 
with controls outside the locality. There was a greater decrease for penicillins resistant 
to beta lactamase, as well as a decrease in the prescribing of penicillins susceptible to 
beta lactamase, consistent with the content of the newsletter. However, there was no 
difference with respect to knowledge and attitudes regarding the correct use of 
antibiotics among the public in the two groups. 
 
4.2.7 Slovenia (Furst et al., 2015) 
 
Multifaceted interventions among all key stakeholder groups in Slovenia decreased 
antibiotic utilisation by 2% to 9% per year from 1999 to 2012, overall by 31%. This 
followed a 24% increase in antibiotic utilisation at the end of the 1990s in Slovenia. 
There were also appreciable changes in the prescribing of different antibiotics.  
 
Table 5 contains some of the multiple initiatives and policies undertaken in Slovenia in 
recent years to reduce overall antibiotic utilisation as well as significantly reduce the 
utilisation of 7 out of 10 antibiotics. 
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Table 5. Some of the activities undertaken in Slovenia to enhance the appropriate use of 
antibiotics (adapted from Fürst et al., 2015) 
 
Activity Institution (organizer) Targeted public Introduction / 
frequency 
2-day symposium on 
antibiotics once a year 
Department of Infectious Diseases 
of the UMC Ljubljana 
GPs 1995 
every year 
Prescribing restrictions for 
amoxicillin/ clavulanic 
acid and the 
fluoroquinolones 
National Health Insurance All physicians 2000/ permanent 
Workshops in Primary 
health centres 
Primary health centres, National 
Health Insurance 
GPs 2001/ sporadically 
Informative budget targets 
for prescribed drugs 
National Health Insurance All physicians 2001/ permanent 
Guidelines on treatment of 
infectious diseases 
Medical professionals GPs 2002 
Audits National Health Insurance All physicians 2002/ regularly 
Workshop on rational 
prescribing of antibiotics 
Faculty of Medicine University of 
Ljubljana 
Specializing GPs 2004/ every year 
Prescribing restrictions for 
cephalosporins 
National Health Insurance All physicians 2005/ permanent 
Booklet "My child has a 
fever" 
National Health Insurance, 
medical professionals 
Parents 2007/ always 
available 
Workshops in regions 
with the highest utilisation 
of antibiotics 
National Committee for the 
Rational Use of Antimicrobials 
GPs 2007/ once a year 
Antibiotic Awareness Day Ministry of Health and the 
National Committee for the 
Rational Use of Antimicrobials 
Lay public and 
GPs 
2008/ every year 
Prescribing restrictions for 
the macrolides 
National Health Insurance  All physicians 2009/ permanent 
Workshop on rational 
prescribing of antibiotics 
Slovenian society of 
chemotherapy 
Young physicians 2010/ every year 
Flyer "Get well without 
antibiotics" 
National Health Insurance, 
medical professionals 
Lay public 2010/ always 
available 
Quality indicators 
including antibiotics 
National Health Insurance GPs 2011 
 
Streptococcus resistance to penicillin decreased, mirroring decreasing utilisation. 
However, Streptococcus resistance to macrolides increased despite their utilisation 
halving and E. coli resistance to fluoroquinolones doubled despite their utilisation 
decreasing by a third.  
 
4.2.8 Thailand (Sumpradit et al., 2012; Action on Antibiotic Resistance, 2015) 
 
The Antibiotics Smart Use programme was initiated to promote rational antibiotic use 
and reduce AMR rates.  
 
Multifaceted interventions at individual and organizational levels were implemented to 
increase public knowledge regarding antibiotics and change antibiotic prescription 
practices among physicians. Interventions at the network and policy levels were used to 
maintain behavior change and scale up the various programmes. Key healthcare 
professionals, including physicians and pharmacists, as well as community leaders were 
trained to promote rational antibiotic use in their healthcare settings and communities. 
Educational materials were also provided for display or distribution to patients.  
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The findings showed that the combined interventions increased public knowledge 
regarding antibiotics and changed their attitudes towards them. Antibiotic utilization 
decreased by 18 to 46% after the programme, and the percentage of patients who were 
not prescribed antibiotics for the three targeted illnesses i.e. acute diarrhea, URTIs, and 
simple wounds, increased by 29.1%. Furthermore, almost all patients who were not 
prescribed antibiotics fully recovered within 7-10 days after the medical visits 
demonstrating that antibiotics were not necessary. 
 
4.2.9 United Kingdom ± Scotland (Nathwani et al., 2011; Colligan et al., 2015) 
 
We have previously documented the initiation and activities of SAPG in Scotland 
(Section 4.1), which significantly reduced Clostridium difficile infection rates. An 
integrated approach to antimicrobial stewardship is being achieved through engagement 
with key stakeholder groups at all levels, aided by implementation of data management 
systems and training materials on antimicrobial stewardship. Improving the treatment of 
infections such as community-acquired pneumonia was also helped by quality 
improvement methodologies. 
 
A self-reported survey in 2014 evaluating stewardship activities by the regional 
Antimicrobial Management Teams (AMTs) as part of the SAPG programme, 
demonstrated good compliance with 9 of the 10 key European indicators. 50% of the 
AMTs achieved all 9 indicators and 100% achieved at least 6 out of the 9 indicators 
(67 %). The authors concluded that collaborative working between SAPG and AMTs, 
together with central funding, has been key to achieving good success, providing 
direction to other countries and regions. 
 
4.3 Impact of educational interventions on public knowledge and attitudes towards 
antibiotics and antibiotic resistance 
 
Numerous public education campaigns have been conducted, particularly in high-
income countries, to improve antibiotic utilization (Finch et al., 2004; Rodis et al., 
2004; Gonzales et al., 2005; Curry et al., 2006; Huttner et al., 2010; Greene et al., 2011; 
Holloway, 2011; McKay et al., 2011; Fürst et al., 2015), some of which have already 
been described earlier. All campaigns have tried to convey that AMR is a major public 
health problem and, in addition, that the misuse of antibiotics contributes to this. 
Furthermore, most campaigns have tried to educate the public that most RTIs are viral 
in origin and consequently should not be treated with antibiotics (Finch et al., 2004; 
Huttner et al., 2010).  
 
The campaigns have used various means of communication. The most common has 
been printed educational materials such as brochures, leaflets and posters. Some 
campaigns have used mass media such as newspapers, radio, television, billboards and 
public-transport advertisements, whilst others have conducted public seminars to 
provide opportunities for interactive education and behavioural change (Freimuth et al., 
2000; Finch et al., 2004; Huttner et al., 2010; Holloway, 2011; Furst et al., 2015). 
Nearly all campaigns have used the internet in some way (Finch et al., 2004; Huttner et 
al., 2010). 
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Table 6 contains details of a number of the campaigns and their impact, building on the 
experiences of Thailand and other countries described above. 
 
Table 6 ± Influence of educational activities among patients 
 
Country Programmes and their influence 
Belgium 
(Goossens et al., 
2006) 
x The majority of the public (79%) who recalled the national antibiotic 
campaign recalled information from the television rather than other 
means of communication 
x Compared with the pre-campaign, patients expectations to be prescribed 
an antibiotic decreased significantly for acute bronchitis, cold, flu, 
diarrhoea and sore throats  
Israel (Hemo et 
al., 2009) 
x Exposure to media campaigns was associated with positive attitudes by 
patients towards antibiotics 
x Parents exposed to the media campaign were more likely to agree with 
current standards of the appropriate prescribing of antibiotics and less 
likely to expect physicians to prescribe antibiotics for RTIs, otitis media 
and pharyngitis than parents not exposed to the campaign 
USA ± North 
Carolina (Greene 
et al., 2011) 
x A pharmacy student-driven education programme raised public 
awareness of the threat of AMR and the appropriate use of antibiotics  
x After participating in the programme, 71% of patients stated that they 
would not now be requesting antibiotics from their physicians  
USA ± Ohio 
(Rodis et al., 
2004) 
x 3DWLHQWV¶NQRZOHGJHDERXWWKHDSSURSULDWHLQGLFDWLRQIRUSUHVFULELQJ
antibiotics improved following a pharmacist-initiated educational 
intervention 
x The post-intervention survey demonstrated a significant increase in the 
% of patients agreeing that antibiotics should not be used for a cold as 
well as for influenza combined with cough and body aches 
 
Shehadeh et al (Shehadeh et al., 2015) recently conducted a study to assess the impact 
of a pharmacist-initiated educational intervention on public knowledge of antibiotics 
and antibiotic resistance in Jordan. The mean knowledge score for the pre- and post-
education was 59.4% and 65.9% respectively. In addition, participants within poor and 
adequate knowledge categories were significantly shifted to the good knowledge 
category after the educational intervention. However, the authors believed the 
improvement in parWLFLSDQWV¶ NQRZOHGJH PD\ not always translate into a change in 
subsequent antibiotic±seeking behavior. 
 
Despite these initiatives, it appears difficult in practice to educate the public about the 
differences between bacterial and viral infections (Finch et al., 2004; Goossens et al., 
2006; Huttner et al., 2010). Telephone surveys among the public in Canada did not 
show any impact of a campaign educating them of the bacterial or viral nature of certain 
infections. Prior to the campaign, 54% of the public agreed that antibiotics are effective 
for the treatment of viral infections. After the campaign, 53% still did not know that 
antibiotics do not work against viruses (NIPA, 2013). In New Zealand, a post-education 
survey demonstrated that the general public still had misconceptions that antibiotics are 
needed to treat viral infections (Curry et al., 2006), and in France54% of the public still 
remained unaware that most URTIs are caused by viruses and do not require antibiotic 
treatment despite successive campaigns over five years (National Health Insurance, 
2008). However, this should not dissuade health authorities from instigating 
programmes in the future to try and educate patients regarding the appropriate use and 
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requests for antibiotics given the impact of inappropriate antibiotic use on increasing 
AMR rates. 
 
Increasing knowledge of antibiotics among the public can result in a paradoxical effect 
(Huttner et al., 2010). In the UK studies have shown that public education campaigns 
are associated with increased knowledge of antibiotics. However, they also resulted in 
increased likelihood of self-medication, sharing antibiotics with someone else and 
keeping leftover antibiotics (McNulty et al., 2007a; McNulty et al., 2007b). This needs 
to be factored into any future campaign. 
 
Care is also needed when translating programmes from one country to another where 
the health systems and context can be different (Holloway, 2011). Typically, 
educational approaches will only be effective if they are tailored to the local context and 
able to address local educational needs and organizational barriers (Siddiqi et al., 2005; 
Sumpradit et al., 2012).  
 
5. Conclusion 
 
The threat of AMR with its impact on morbidity, mortality and costs is growing. As a 
result, becoming one of the most critical problems facing healthcare systems world-
wide. A number of inter-linking strategies are needed to address this. These include 
enhancing access where co-payments are an issue, reducing inappropriate prescribing 
(conservatism) where this is a problem as well as encouraging the development of new 
antibiotics given the current scarcity (Hoffman & Outterson, 2015; O'Neill, 2015). 
Knowledge regarding current utilisation and resistance patterns in a country or region is 
a pre-requisite to instigating future interventions to improve future rational prescribing 
and dispensing of antibiotics (WHO Europe, 2014).  
 
We have shown that multiple approaches, including all key stakeholder groups such as 
health authorities, physicians, pharmacists and patients, are needed to reduce 
inappropriate antibiotic prescribing. Within this, physicians and pharmacists are 
particularly important with FIP urging a number of activities among pharmacists and 
governments (Box 1). This is endorsed by the WHO in Europe (Box 2). Activities need 
to be continually analysed and sustained for maximum impact given the misconceptions 
WKDWFDQVWLOOUHPDLQFRXSOHGZLWKSHRSOH¶V short memories from one year to the next.  
 
We will continue to monitor the impact of the interventions across regions and countries 
to reduce future inappropriate prescribing and dispensing of antibiotics to provide 
direction to others to address this critical area. 
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